KR100206481B1 - Galenic form for ocular administration and process for the preparation of same - Google Patents
Galenic form for ocular administration and process for the preparation of same Download PDFInfo
- Publication number
- KR100206481B1 KR100206481B1 KR1019940703939A KR19940703939A KR100206481B1 KR 100206481 B1 KR100206481 B1 KR 100206481B1 KR 1019940703939 A KR1019940703939 A KR 1019940703939A KR 19940703939 A KR19940703939 A KR 19940703939A KR 100206481 B1 KR100206481 B1 KR 100206481B1
- Authority
- KR
- South Korea
- Prior art keywords
- preparation
- same
- ocular administration
- galenic form
- galenic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR92/05514 | 1992-05-05 | ||
FR9205514A FR2690846B1 (fr) | 1992-05-05 | 1992-05-05 | Forme galenique pour administration oculaire et procede de preparation. |
PCT/FR1993/000433 WO1993021901A1 (fr) | 1992-05-05 | 1993-05-05 | Forme galenique pour administration oculaire et procede de preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
KR950701214A KR950701214A (ko) | 1995-03-23 |
KR100206481B1 true KR100206481B1 (en) | 1999-07-01 |
Family
ID=9429535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019940703939A KR100206481B1 (en) | 1992-05-05 | 1994-11-04 | Galenic form for ocular administration and process for the preparation of same |
Country Status (8)
Country | Link |
---|---|
US (1) | US5766619A (ko) |
EP (1) | EP0639069B1 (ko) |
JP (1) | JP3208568B2 (ko) |
KR (1) | KR100206481B1 (ko) |
DE (1) | DE69314950T2 (ko) |
ES (1) | ES2109493T3 (ko) |
FR (1) | FR2690846B1 (ko) |
WO (1) | WO1993021901A1 (ko) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19511322C2 (de) * | 1995-03-28 | 1999-09-02 | Mann Gerhard Chem Pharm Fab | Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung |
WO2000040089A1 (en) * | 1999-01-05 | 2000-07-13 | Massachusetts Eye And Ear Infirmary | Targeted transscleral controlled release drug delivery to the retina and choroid |
US6416777B1 (en) * | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
ATE290837T1 (de) | 1999-10-21 | 2005-04-15 | Alcon Inc | Medikamentenversorgung der sub-tenon |
BR0014929B1 (pt) | 1999-10-21 | 2009-01-13 | dispositivo para distribuiÇço de medicamento oftÁlmico. | |
US7943162B2 (en) * | 1999-10-21 | 2011-05-17 | Alcon, Inc. | Drug delivery device |
WO2002089767A1 (en) | 2001-05-03 | 2002-11-14 | Massachusetts Eye And Ear Infirmary | Implantable drug delivery device and use thereof |
EP1409065B1 (en) | 2001-07-23 | 2007-01-17 | Alcon, Inc. | Ophthalmic drug delivery device |
ES2271301T3 (es) * | 2001-07-23 | 2007-04-16 | Alcon, Inc. | Dispositivo de suministro de farmaco oftalmico. |
WO2003092665A2 (en) * | 2002-05-02 | 2003-11-13 | Massachusetts Eye And Ear Infirmary | Ocular drug delivery systems and use thereof |
US20060167435A1 (en) * | 2003-02-18 | 2006-07-27 | Adamis Anthony P | Transscleral drug delivery device and related methods |
JP2007505932A (ja) * | 2003-09-18 | 2007-03-15 | マクサイト, インコーポレイテッド | 経強膜送達 |
US8663639B2 (en) * | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
CA2597590A1 (en) * | 2005-02-09 | 2006-08-17 | Macusight, Inc. | Formulations for ocular treatment |
JP2009502954A (ja) | 2005-07-27 | 2009-01-29 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイティド | タンパク質のミスフォールディングを修正する小分子及びその使用 |
WO2007013590A1 (ja) * | 2005-07-29 | 2007-02-01 | Santen Pharmaceutical Co., Ltd. | 固形組成物を用いた後眼部組織への非侵襲性ドラッグデリバリーシステム |
UA94427C2 (ru) | 2005-11-29 | 2011-05-10 | Смиткляйн Бичам Корпорейшн | Фармацевтическая композиция для местного лечения неоваскулярных расстройств глаз |
US8492400B2 (en) | 2006-02-09 | 2013-07-23 | Santen Pharmaceutical Co., Ltd. | Stable formulations, and methods of their preparation and use |
CN103127100A (zh) | 2006-03-23 | 2013-06-05 | 参天制药株式会社 | 用于与血管通透性有关的疾病或病症的制剂和方法 |
US20080265343A1 (en) * | 2007-04-26 | 2008-10-30 | International Business Machines Corporation | Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof |
US8372036B2 (en) | 2009-05-06 | 2013-02-12 | Alcon Research, Ltd. | Multi-layer heat assembly for a drug delivery device |
IN2012DN00352A (ko) | 2009-06-16 | 2015-08-21 | Bikam Pharmaceuticals Inc | |
US20120232102A1 (en) | 2009-09-30 | 2012-09-13 | Chun-Fang Xu | Methods Of Administration And Treatment |
US8177747B2 (en) | 2009-12-22 | 2012-05-15 | Alcon Research, Ltd. | Method and apparatus for drug delivery |
WO2012174064A1 (en) | 2011-06-14 | 2012-12-20 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
WO2013058809A1 (en) | 2011-10-19 | 2013-04-25 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
JP6126118B2 (ja) | 2011-11-30 | 2017-05-10 | ビカム ファーマスーティカルス,インコーポレイテッド | オプシン結合性リガンド、組成物、及び使用方法 |
AU2012346537A1 (en) | 2011-12-01 | 2014-07-17 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
CN109549922B (zh) * | 2018-12-27 | 2021-04-20 | 湖北远大天天明制药有限公司 | 一种托吡卡胺眼用组合物及其制备方法与应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3630200A (en) * | 1969-06-09 | 1971-12-28 | Alza Corp | Ocular insert |
SE352811B (ko) * | 1971-06-04 | 1973-01-15 | Pharmacia Ab | |
US3986510A (en) * | 1971-09-09 | 1976-10-19 | Alza Corporation | Bioerodible ocular device |
US3828777A (en) * | 1971-11-08 | 1974-08-13 | Alza Corp | Microporous ocular device |
-
1992
- 1992-05-05 FR FR9205514A patent/FR2690846B1/fr not_active Expired - Lifetime
-
1993
- 1993-05-04 US US08/331,603 patent/US5766619A/en not_active Expired - Lifetime
- 1993-05-05 DE DE69314950T patent/DE69314950T2/de not_active Expired - Lifetime
- 1993-05-05 ES ES93910086T patent/ES2109493T3/es not_active Expired - Lifetime
- 1993-05-05 EP EP93910086A patent/EP0639069B1/fr not_active Expired - Lifetime
- 1993-05-05 JP JP51901293A patent/JP3208568B2/ja not_active Expired - Fee Related
- 1993-05-05 WO PCT/FR1993/000433 patent/WO1993021901A1/fr active IP Right Grant
-
1994
- 1994-11-04 KR KR1019940703939A patent/KR100206481B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1993021901A1 (fr) | 1993-11-11 |
JPH07506356A (ja) | 1995-07-13 |
DE69314950T2 (de) | 1998-04-16 |
US5766619A (en) | 1998-06-16 |
FR2690846A1 (fr) | 1993-11-12 |
EP0639069A1 (fr) | 1995-02-22 |
FR2690846B1 (fr) | 1995-07-07 |
ES2109493T3 (es) | 1998-01-16 |
EP0639069B1 (fr) | 1997-10-29 |
DE69314950D1 (de) | 1997-12-04 |
KR950701214A (ko) | 1995-03-23 |
JP3208568B2 (ja) | 2001-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100206481B1 (en) | Galenic form for ocular administration and process for the preparation of same | |
AU627845B2 (en) | Improvements in or relating to devices for administration of drugs or the like | |
AU7672294A (en) | Compositions and methods for the administration of delta-aminolevulinic acid | |
IL105683A0 (en) | Ophthalmologic cannula | |
HU896428D0 (en) | Process for the preparation of imidazoles and pharmaceutical compositions thereof | |
AU3720193A (en) | Hydroisoindolines and hydroisoquinolines as psychotropic drugs | |
AU3699293A (en) | Stabilized solid pharmaceutical preparation and method of producing the same | |
AU2490492A (en) | Process for the preparation of beta-phenylisoserine derivatives and use thereof | |
HU896479D0 (en) | Process for the preparation of capsaycin derivatives and pharmaceutical compositions thereof | |
HU896612D0 (en) | Process for the preparation of 2-iminebenzothiazole derivatives and pharmaceutical compositions thereof | |
HRP931429B1 (en) | Process for the preparation of amlodipin benzensulphonate | |
HUT59319A (en) | Pharmaceutical compositions with controlled release of active ingredient and process for producing same | |
IL99077A0 (en) | New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them | |
HUT46660A (en) | Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient | |
ZA941199B (en) | Physiologically active compound HS-1 and process for the preparation of the same | |
HUT62760A (en) | Nematocidal compositions comprising pyrimidine derivatives as active ingredient and process for producing the active ingredient | |
HUT47127A (en) | Process for producing pyrimidine derivatives and pharmaceutical compositions comprising such active ingredient | |
AU7736991A (en) | Device and method for enhanced administration of physostigmine | |
GR3024654T3 (en) | Benzofuranone and benzodifurantrione derivatives and process for the preparation of benzodifuranones. | |
HRP940315A2 (en) | Process for the preparation of pharmaceutical compositions containinbg active ingredient | |
ZA975168B (en) | Devices intended for the transdermic administration of trimegestone their preparation process and their use as medicaments | |
HUT60711A (en) | Process for producing new crystalline (s)-norfluoxetine and pharmaceutical composition comprising the active ingredient | |
HU896636D0 (en) | Process for the preparation of polyhydroxy-benzyloxypropanolamines and pharmaceutical compositions thereof | |
HUT49364A (en) | Process for producing sialosylglyceride derivatives and pharmaceutical compositions comprising such active ingredient | |
HUT61878A (en) | Nematocidal compositions comprising pyrimidine derivatives as active ingredient and process for producing the active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120323 Year of fee payment: 14 |
|
EXPY | Expiration of term |